Earnings Estimates for Various Companies Boosted by Analysts

Analysts from Zacks Research and US Capital Advisors issued positive earnings estimates for several companies, including Halozyme Therapeutics, CDW Corporation, and Antero Midstream Corporation. Other companies, such as Prestige Consumer Healthcare and Akamai Technologies, received bearish estimates. The changes reflect the analysts' revised expectations for the companies' future performance.

Analyst teams from Zacks Research and US Capital Advisors have issued forecasts that boost earnings estimates for several companies, including Halozyme Therapeutics and CDW Corporation [doc1, doc10]. Zacks Research analysts now expect Halozyme Therapeutics to earn $1 in Q3 2026, while CDW is anticipated to post higher earnings per share (EPS) in Q2 2026 [doc1, doc10].

Meanwhile, Zacks Research analysts have lowered their Q2 2027 earnings estimates for Prestige Consumer Healthcare and Q3 2027 estimates for Antero Midstream [doc7, doc11]. A bearish outlook has also been issued for Akamai Technologies for FY2026 earnings by Zacks Research .

The changes in earnings estimates reflect the analysts' evolving views on the companies' future performance and highlight the potential for varying expectations among investors.

Earnings Estimates for Various Companies Boosted by Analysts

Related Stocks